Insider Trading Intelligence

…

FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Track what insiders are doing with their own money.

Product

Insider trades Congress trades Financials Stock screener Pricing

Data

SEC EDGAR House.gov Senate.gov Methodology Data Status

Company

About Blog Terms Privacy

© 2026 MarketPeel, Inc.NOT INVESTMENT ADVICE · DATA VIA SEC EDGAR

Home
Stocks
Health Care
PUMA BIOTECHNOLOGY, INC. (PBYI)

PUMA BIOTECHNOLOGY, INC.

PBYI

NASDAQHealth Care

Pharmaceuticals · LOS ANGELES, CA, United States

$7.85

-3.89% (-$0.32)2026-07-09

Smart-Money SignalNeutral · 45/100— Insiders are net sellers over 90 days (-$1.1M, 8 sales vs 1 buy)

Revenue$44.8M

Net Income-$3.8M

EPS$-0.07

Market Cap$399.5M

Price Performance

Historical data including institutional events

Company Profile

A

Alan Auerbach

CEO & Executive Director

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

Founded: 2010
Employees: 265
Headquarters: LOS ANGELES, CA, United States
Website: www.pumabiotechnology.com

Peer ComparisonRevenue ($B)

▾

Loading company sections...